Xeljanz
Country: European Union
Language: Finnish
Source: EMA (European Medicines Agency)
Public Assessment Report
(PAR)
26-07-2013
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Tofacitinib
Available from:
Pfizer Limited
INN (International Name):
tofacitinib
Therapeutic group:
immunosuppressantit
Therapeutic area:
Niveltulehdus, nivelreuma
Therapeutic indications:
Nivelreuman hoidossa.
Authorization status:
Refused
